The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Ocular side effects possibly associated with isotretinoin usage
Abstract
PURPOSE To evaluate reported ocular side effects associated with isotretinoin usage. METHODS One thousand seven hundred forty-one case reports received from spontaneous reporting systems, data from the Drug Safety Section of Roche Pharmaceuticals, and the world's literature were evaluated using the World Health Organization Causality Assessment Guide of Suspected Adverse Reactions. RESULTS Thirty-eight different signs or symptoms of ocular abnormalities associated with isotretinoin usage have been classified as "certain," "probable/likely," "possible," "unlikely," or "conditional/unclassifiable." CONCLUSION Adverse ocular side effects secondary to isotretinoin that are "certain" include abnormal meibomian gland secretion, blepharoconjunctivitis, corneal opacities, decreased dark adaptation, decreased tolerance to contact lens, decreased vision, increased tear osmolarity, keratitis, meibomian gland atrophy, myopia, ocular discomfort, ocular sicca, photophobia, and teratogenic ocular abnormalities. Those that are "probable/likely" are decreased color vision (reversible) and permanent loss of dark adaptation. Those that have a "possible" association include permanent keratoconjunctivitis sicca. Suggested guidelines for ocular examination for patients on isotretinoin are given.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lammer, E. J., Chen, D. T., Hoar, R. M., Agnish, N. D., Benke, P. J., Braun, J. T., Curry, C. J., Fernhoff, P. M., Grix, A. W., Lott, I. T., et al. (1985) · New England Journal of Medicine · doi:10.1056/nejm198510033131401 · Cited by 1,942
Isotretinoin therapy for acne: results of a multicenter dose-response study
Strauss, J. S., Rapini, R. P., Shalita, A. R., Konecky, E., Pochi, P. E., Comite, H., & Exner, J. H. (1984) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(84)80100-0 · Cited by 223
The treatment of severe cystic acne with 13-cis-retinoic acid
Farrell, L. N., Strauss, J. S., & Stranieri, A. M. (1980) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(80)80074-0 · Cited by 194
Cited by
TFOS DEWS II pathophysiology report
Bron, A. J., de Paiva, C. S., Chauhan, S. K., Bonini, S., Gabison, E. E., Jain, S., Knop, E., Markoulli, M., Ogawa, Y., Perez, V., et al. (2017) · The Ocular Surface · doi:10.1016/j.jtos.2017.05.011 · Cited by 1,815
Knop, E., Knop, N., Millar, T., Obata, H., & Sullivan, D. A. (2011) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.10-6997c · Cited by 1,061
Radu, R. A., Mata, N. L., Nusinowitz, S., Liu, X., Sieving, P. A., & Travis, G. H. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0737855100 · Cited by 227
Oral isotretinoin for acne: a complete overview
Villani, A., Nastro, F., Di Vico, F., Fabbrocini, G., Annunziata, M. C., & Genco, L. (2022) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2022.2102605 · Cited by 42
Metadata
- Authors
- Fraunfelder, F. T., Fraunfelder, F. W., & Edwards, R.
- Venue
- American Journal of Ophthalmology
- Publisher
- Elsevier BV
- Published
- 2001-09
- Volume
- 132
- Issue
- 3
- Pages
- 299-305
- ISSN
- 0002-9394 (ISSN-L)
- OpenAlex
- W1975559715
- Cited by
- 179
- References
- 3
- FWCI
- 3.82
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Ocular side effects possibly associated with isotretinoin usage. https://app.cochat.ai/papers/10.1016/s0002-9394(01)01024-8
- The paper
- Fraunfelder, F. T., Fraunfelder, F. W., & Edwards, R. (2001). Ocular side effects possibly associated with isotretinoin usage. American Journal of Ophthalmology. https://doi.org/10.1016/s0002-9394(01)01024-8
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.